Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders
- PMID: 23133788
- PMCID: PMC3485523
- DOI: 10.1155/2012/391438
Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders
Abstract
Protein clearance is critical for the maintenance of the integrity of neuronal cells, and there is accumulating evidence that in most-if not all-neurodegenerative disorders, impaired protein clearance fundamentally contributes to functional and structural alterations eventually leading to clinical symptoms. Dysfunction of protein clearance leads to intra- and extraneuronal accumulation of misfolded proteins and aggregates. The pathological hallmark of Lewy body disorders (LBDs) is the abnormal accumulation of misfolded proteins such as alpha-synuclein (Asyn) and amyloid-beta (Abeta) in a specific subset of neurons, which in turn has been related to deficits in protein clearance. In this paper we will highlight common intraneuronal (including autophagy and unfolded protein stress response) and extraneuronal (including interaction of neurons with astrocytes and microglia, phagocytic clearance, autoimmunity, cerebrospinal fluid transport, and transport across the blood-brain barrier) protein clearance mechanisms, which may be altered across the spectrum of LBDs. A better understanding of the pathways underlying protein clearance-in particular of Asyn and Abeta-in LBDs may result in the identification of novel biomarkers for disease onset and progression and of new therapeutic targets.
Figures

Similar articles
-
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.Front Aging Neurosci. 2021 Jun 25;13:690293. doi: 10.3389/fnagi.2021.690293. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34248606 Free PMC article. Review.
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
-
Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils.Methods Mol Biol. 2019;1948:45-57. doi: 10.1007/978-1-4939-9124-2_5. Methods Mol Biol. 2019. PMID: 30771169 Free PMC article.
-
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.PLoS One. 2012;7(10):e48042. doi: 10.1371/journal.pone.0048042. Epub 2012 Oct 25. PLoS One. 2012. PMID: 23133543 Free PMC article.
-
Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.J Neurosci. 2017 Apr 12;37(15):4023-4031. doi: 10.1523/JNEUROSCI.3442-16.2017. Epub 2017 Mar 8. J Neurosci. 2017. PMID: 28275161 Free PMC article.
Cited by
-
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27. Brain. 2014. PMID: 25351739 Free PMC article.
-
A Prospective Viewpoint on Neurological Diseases and Their Biomarkers.Molecules. 2022 May 30;27(11):3516. doi: 10.3390/molecules27113516. Molecules. 2022. PMID: 35684455 Free PMC article. Review.
-
Concomitant protein pathogenesis in Parkinson's disease and perspective mechanisms.Front Aging Neurosci. 2023 Apr 27;15:1189809. doi: 10.3389/fnagi.2023.1189809. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37181621 Free PMC article. Review.
-
Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.Neurotherapeutics. 2016 Jan;13(1):179-89. doi: 10.1007/s13311-015-0397-z. Neurotherapeutics. 2016. PMID: 26494242 Free PMC article. Review.
-
Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns.J Neuroinflammation. 2024 Dec 3;21(1):317. doi: 10.1186/s12974-024-03293-3. J Neuroinflammation. 2024. PMID: 39627772 Free PMC article.
References
-
- Kahle PJ. α-Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathologica. 2008;115(1):87–95. - PubMed
-
- Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Reviews in Molecular Medicine. 2009;11, article e22 - PubMed
-
- Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007;68(11):812–819. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources